Xponance’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,762
| Closed | -$231K | – | 1470 |
|
|
2024
Q4 | $231K | Buy |
+7,762
| New | +$231K | ﹤0.01% | 1238 |
|
|
2024
Q2 | – | Sell |
-13,623
| Closed | -$213K | – | 1353 |
|
|
2024
Q1 | $213K | Sell |
13,623
-352
| -3% | -$5.5K | ﹤0.01% | 1171 |
|
|
2023
Q4 | $209K | Sell |
13,975
-400
| -3% | -$5.97K | ﹤0.01% | 1147 |
|
|
2023
Q3 | $232K | Buy |
14,375
+8
| +0.1% | +$129 | ﹤0.01% | 1091 |
|
|
2023
Q2 | $596K | Buy |
14,367
+260
| +2% | +$10.8K | 0.01% | 834 |
|
|
2023
Q1 | $848K | Buy |
14,107
+105
| +0.7% | +$6.32K | 0.01% | 709 |
|
|
2022
Q4 | $1.03M | Buy |
14,002
+1,778
| +15% | +$130K | 0.02% | 630 |
|
|
2022
Q3 | $929K | Buy |
12,224
+202
| +2% | +$15.4K | 0.02% | 604 |
|
|
2022
Q2 | $836K | Buy |
12,022
+383
| +3% | +$26.6K | 0.02% | 632 |
|
|
2022
Q1 | $964K | Buy |
11,639
+133
| +1% | +$11K | 0.02% | 606 |
|
|
2021
Q4 | $864K | Sell |
11,506
-184
| -2% | -$13.8K | 0.01% | 667 |
|
|
2021
Q3 | $1.36M | Sell |
11,690
-274
| -2% | -$31.8K | 0.03% | 454 |
|
|
2021
Q2 | $2.65M | Buy |
11,964
+1,570
| +15% | +$348K | 0.05% | 301 |
|
|
2021
Q1 | $1.37M | Sell |
10,394
-94
| -0.9% | -$12.4K | 0.03% | 390 |
|
|
2020
Q4 | $1.82M | Buy |
10,488
+86
| +0.8% | +$14.9K | 0.04% | 329 |
|
|
2020
Q3 | $1.16M | Sell |
10,402
-37
| -0.4% | -$4.12K | 0.03% | 387 |
|
|
2020
Q2 | $619K | Buy |
+10,439
| New | +$619K | 0.02% | 509 |
|